Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.
暂无分享，去创建一个
V. Najfeld | R. Levine | M. Salama | A. Dueck | R. Hoffman | R. Mesa | J. Goldberg | C. Abboud | J. Mascarenhas | M. Kremyanskaya | H. Kosiorek | M. Heaney | E. Hexner | R. Rampal | R. Weinberg | K. Menghrajani | L. Price | D. Berenzon | L. Sandy